No Benefit Seen With Adjuvant Nivolumab in Gastric/GEJ Cancer
Adding nivolumab to adjuvant chemotherapy did not improve relapse-free survival in a phase 3 trial of patients with gastric/GEJ cancer.
Gastrointestinal Cancers News
GASTROINTESTINAL CANCER ADVISOR
Gastrointestinal Cancers News
NALIRIFOX Deemed New Reference Regimen for Untreated Metastatic PDAC
NALIRIFOX can improve survival vs gemcitabine plus nab-paclitaxel in patients with previously untreated, metastatic pancreatic ductal adenocarcinoma, a phase 3 trial suggests.
Neoadjuvant FOLFIRINOX Does Not Improve OS in Resectable Pancreatic Cancer
Neoadjuvant FOLFIRINOX does not provide a survival benefit over upfront surgery in resectable pancreatic cancer, a phase 2 study suggests.
Palliative Care Does Not Improve HRQOL in Context of Gastrointestinal Cancer Surgery
Palliative care does not improve health-related quality of life among patients undergoing curative-intent surgery for upper gastrointestinal cancer, a study suggests.
Red-Flag Signs and Symptoms of Early-Onset Colorectal Cancer
Abdominal pain, rectal bleeding, diarrhea, and iron deficiency anemia were associated with early-onset CRC.
Adding Cixutumumab to Paclitaxel Does Not Improve Outcomes in Esophageal/GEJ Cancer
In metastatic esophageal/gastroesophageal junction cancer, the addition of cixutumumab to paclitaxel does not improve outcomes vs paclitaxel alone.
Cancer Death Rates Vary Across Congressional Districts
Cancer death rates in the US have declined in recent years, but the declines vary by congressional district, a study suggests.
Participation in Cancer Screening Low for Those With Severe Mental Illness
Participation in bowel, breast, and cervical cancer screening is lower for people with severe mental illness, researchers found.
High TMB Associated With Better Outcomes of ICI Therapy in Advanced Cancers
Patients with advanced cancer have better outcomes if they have high TMB prior to treatment with an ICI, new research suggests.
BMI Over Time Tied to Risk of CRC and Other GI Cancers
Patients who are overweight or obese in early, middle, or late adulthood may have an increased risk of gastrointestinal cancers, a study suggests.
HIPEC With Mitomycin C Improves Locoregional Control in Colon Cancer
Adding HIPEC and mitomycin C to surgical resection improves locoregional control in patients with locally advanced colon cancer, a study suggests.
Neoadjuvant Chemoimmunotherapy Deemed Safe, Effective in Esophageal Cancer
Neoadjuvant chemotherapy combined with an immune checkpoint inhibitor is safe and effective in patients with resectable esophageal cancer, a real-world study suggests.
Factors Associated With Pulmonary Metastasectomy in Colorectal Cancer
A study of patients with advanced lung-limited colorectal cancer has revealed factors associated with undergoing pulmonary metastasectomy.
Food Deserts, Swamps Linked to Increased Risk of Death From Obesity-Related Cancers
US counties with food deserts or food swamps tend to have higher rates of death from obesity-related cancers, a study suggests.
Adding Bevacizumab to Trifluridine-Tipiracil Improves PFS, OS in Metastatic CRC
Adding bevacizumab to treatment with trifluridine-tipiracil improves outcomes in patients with refractory, metastatic colorectal cancer, a phase 3 study suggests.
Sex Hormones Linked to Risk of Gastrointestinal Cancers
Higher levels of certain sex hormones are associated with an increased risk of some gastrointestinal cancers, a meta-analysis suggests.
Educational DVD and Patient Navigation Increase Cancer Screenings in Rural Patients
An educational DVD and patient navigation via phone can improve adherence to cancer screening in rural patients, a study suggests.
Lack of Access to Abortion Has Had a Negative Impact on Cancer Care
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Risk for Early-Onset CRC Increased in Women Born via C-Section
Birth by cesarean delivery is associated with early-onset colorectal cancer only in female offspring, a study suggests.
Cancer Death Rates Higher in NHPI Patients Than in Asian Patients
A new study has revealed “stark” differences in cancer death rates between Asian patients and NHPI patients in the US, according to researchers.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Expertscape
Loading... 
Loading...